FDMT Net Tangible Assets from 2010 to 2026
| FDMT Stock | USD 8.99 0.60 7.15% |
Net Tangible Assets | First Reported 2010-12-31 | Previous Quarter 266 M | Current Value 279.3 M | Quarterly Volatility 146.5 M |
Check 4D Molecular financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among 4D Molecular's main balance sheet or income statement drivers, such as Net Interest Income of 32.7 M, Interest Income of 32.7 M or Depreciation And Amortization of 8.1 M, as well as many indicators such as Price To Sales Ratio of 7.7 K, Dividend Yield of 0.0 or PTB Ratio of 0.56. FDMT financial statements analysis is a perfect complement when working with 4D Molecular Valuation or Volatility modules.
FDMT | Net Tangible Assets | Build AI portfolio with FDMT Stock |
The evolution of Net Tangible Assets for 4D Molecular Therapeutics provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how 4D Molecular compares to historical norms and industry peers.
Latest 4D Molecular's Net Tangible Assets Growth Pattern
Below is the plot of the Net Tangible Assets of 4D Molecular Therapeutics over the last few years. It is the total assets of a company minus any intangible assets such as patents, copyrights, and goodwill; it represents the physical assets of a company. 4D Molecular's Net Tangible Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in 4D Molecular's overall financial position and show how it may be relating to other accounts over time.
| Net Tangible Assets | 10 Years Trend |
|
Net Tangible Assets |
| Timeline |
FDMT Net Tangible Assets Regression Statistics
| Arithmetic Mean | 91,623,822 | |
| Geometric Mean | 62,388,414 | |
| Coefficient Of Variation | 159.89 | |
| Mean Deviation | 138,060,614 | |
| Median | (19,590,000) | |
| Standard Deviation | 146,492,870 | |
| Sample Variance | 21460.2T | |
| Range | 392.1M | |
| R-Value | 0.82 | |
| Mean Square Error | 7613.5T | |
| R-Squared | 0.67 | |
| Significance | 0.000063 | |
| Slope | 23,699,506 | |
| Total Sum of Squares | 343362.6T |
FDMT Net Tangible Assets History
About 4D Molecular Financial Statements
4D Molecular shareholders use historical fundamental indicators, such as Net Tangible Assets, to determine how well the company is positioned to perform in the future. Although 4D Molecular investors may analyze each financial statement separately, they are all interrelated. The changes in 4D Molecular's assets and liabilities, for example, are also reflected in the revenues and expenses on on 4D Molecular's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Net Tangible Assets | 266 M | 279.3 M |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for FDMT Stock Analysis
When running 4D Molecular's price analysis, check to measure 4D Molecular's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy 4D Molecular is operating at the current time. Most of 4D Molecular's value examination focuses on studying past and present price action to predict the probability of 4D Molecular's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move 4D Molecular's price. Additionally, you may evaluate how the addition of 4D Molecular to your portfolios can decrease your overall portfolio volatility.